Novartis wants more digital—and needs better compliance—and it's shuffling executives to do it

Novartis wants more digital—and needs better compliance—and it's shuffling executives to do it

Novartis' new executive team steps up its focus on manufacturing tech, digital efforts and ethics revamp. (Novartis)

Novartis just rejigged its executive committee for three obvious reasons: Its operations chief is leaving, it’s aiming for big things in digital and it needs to tighten focus on ethics and compliance after a series of scandals around the globe.

André Wyss, the Swiss drugmaker’s director of operations, is making a quick exit to “pursue opportunities outside of Novartis,” the company said in a Monday statement. His job will be divided up, but only one of his three successors joins the top brass.